Hyattsville, Maryland Clinical Trials

A listing of Hyattsville, Maryland clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 50 clinical trials
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for …

MedStar Washington Hospital Center
 (5.4 away) Contact site
  • 247 views
  • 28 Nov, 2020
  • +270 other locations
Study of Pembrolizumab (MK-3475) Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-7339-010/KEYLYNK-010)

The purpose of this study is to assess the efficacy and safety of the combination of the polyadenosine 5'-diphosphoribose poly(ADP-ribose) polymerase (PARP) inhibitor olaparib and pembrolizumab in the treatment of participants with mCRPC who have failed to respond to either abiraterone acetate or enzalutamide (but not both) and to chemotherapy. …

MRI
castration-resistant prostate cancer
serum testosterone
diphosphonates
bisphosphonate
Sibley Memorial Hospital ( Site 0096)
 (8.1 away) Contact site
  • 394 views
  • 04 Dec, 2020
  • +202 other locations
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

The purpose of this study is to collect long term safety data in subjects who are continuing to derive clinical benefit from treatment with Enzalutamide from the subjects participation in an enzalutamide clinical study sponsored by Astellas or Medivation (i.e., parent study) which has completed, at a minimum, the primary …

abiraterone
androgens
prednisone
androgen suppression
antiandrogen therapy
Site US10050
 (7.0 away) Contact site
  • 1404 views
  • 05 Dec, 2020
  • +130 other locations
A Prospective Comparative Study of Outcomes With Proton and Photon Radiation in Prostate Cancer

This study is a large, prospective, pragmatic, controlled comparison of patient-centric outcomes [quality of life (QOL), toxicity, and disease control] between parallel cohorts of men with prostate cancer treated simultaneously at proton therapy facilities and at geographically similar conventional (photon-based) radiation facilities using intensity-modulated radiation therapy (IMRT) techniques.

bone scan
adenocarcinoma of prostate
adenocarcinoma
metastasis
University of Maryland
 (2.8 away) Contact site
  • 302 views
  • 20 May, 2020
  • +48 other locations
Phase 3 Study of ProstAtak Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer

The purpose of this study is to evaluate the effectiveness of ProstAtak immunotherapy in combination with radiation therapy for patients with intermediate-high risk localized prostate cancer. ProstAtak kills tumor cells and stimulates a cancer vaccine effect. Killing tumor cells in an immune stimulatory environment induces the body's immune system to …

androgens
androgen suppression
antiandrogen therapy
cancer vaccine
tumor cells
Sibley Memorial Hospital
 (8.2 away) Contact site
  • 1420 views
  • 05 Dec, 2020
  • +76 other locations
HealthMindr App to Increase Pre-exposure Prophylaxis (PrEP) Uptake and Retention Among Men Who Have Sex With Men (MSM)

This study is a randomized controlled clinical trial of a theoretically based mobile app, HealthMindr, to increase pre-exposure prophylaxis (PrEP) uptake among men who have sex with men (MSM) to prevent human immunodeficiency virus (HIV). Participants in the intervention arm will receive access to the HealthMindr app, with information about …

pre-exposure prophylaxis (prep)
immunodeficiency
George Washington University
 (7.0 away) Contact site
  • 141 views
  • 14 May, 2020
  • +2 other locations
Combining CRLX101 a Nanoparticle Camptothecin With Enzalutamide in People With Progressive Metastatic Castration Resistant Prostate Cancer Following Prior Enzalutamide Treatment

Background Some prostate cancer keeps growing even when testosterone in the body drops to very low levels. This is called castrate-resistant prostate cancer. One treatment is enzalutamide. This is a modern hormonal therapy. But it only works for a certain amount of time and then the cancer becomes resistant to …

dutasteride
finasteride
bone scan
hormone therapy
antiandrogens
National Institutes of Health Clinical Center
 (9.7 away) Contact site
  • 14 views
  • 31 Aug, 2020
  • 1 location
Study of I-131-1095 Radiotherapy in Combination With Enzalutamide in Patients With Metastatic Castration-resistant Prostate Cancer Who Are Chemotherapy Naive and Have Progressed on Abiraterone

This is a multicenter, randomized, controlled, phase 2 clinical trial designed to evaluate the safety and efficacy of I-131-1095 radiotherapy in combination with enzalutamide compared to enzalutamide alone in patients with prostate-specific membrane antigen (PSMA)-avid metastatic castration resistant prostate cancer (mCRPC) who have progressed on abiraterone. Patients must be chemotherapy-naive …

bone scan
taxane
castration-resistant prostate cancer
serum testosterone
diphosphonates
Medstar Georgetown University Hospital
 (7.9 away) Contact site
  • 23 views
  • 20 Nov, 2020
  • +23 other locations
Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Men With Stage D0 Prostate Cancer

Background Men who continue to have an elevated or rising prostate specific antigen (PSA) level after their primary prostate cancer treatment are at increased risk for their cancer to progress. The time it takes to progress is highly variable. One way to predict this progression is based on the change …

anticoagulants
dutasteride
finasteride
bone scan
prostatectomy
National Institutes of Health Clinical Center, 9000 Rockville Pike
 (9.7 away) Contact site
  • 6 views
  • 30 Sep, 2020
  • 1 location
Docetaxel With or Without Ascorbic Acid in Treating Patients With Metastatic Prostate Cancer

This randomized phase II trial studies how well docetaxel works when given with or without ascorbic acid in treating patients with prostate cancer that has spread to other places in the body. Drugs used in chemotherapy, such as docetaxel, work in different ways to stop the growth of tumor cells, …

carcinoma
docetaxel
absolute neutrophil count
testosterone
castration-resistant prostate cancer
Sibley Memorial Hospital
 (8.2 away) Contact site
  • 25 views
  • 26 Jul, 2020
  • +5 other locations